JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

Memorial Sloan Kettering Westchester, Harrison

Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.

Sarah Cannon Research Institute at TriStar Health, Nashville

The University of Chicago Medicine Comprehensive Cancer Center, Chicago

Washington University School of Medicine, St Louis

The University of Texas - MD Anderson Cancer Center, Houston

South Texas Accelerated Research Therapeutics, LLC, San Antonio

Sarah Cannon Research Institute at HealthONE, Denver

Stanford University School of Medicine, Palo Alto

University of Washington, Seattle

Yale New Haven Hospital, New Haven

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

Memorial Sloan Kettering Monmouth, Middletown